Scott Robert Henry Sells 3,000 Shares of NEXGEL, Inc. (NASDAQ:NXGL) Stock

NEXGEL, Inc. (NASDAQ:NXGLGet Free Report) Director Scott Robert Henry sold 3,000 shares of the firm’s stock in a transaction dated Tuesday, January 7th. The shares were sold at an average price of $3.37, for a total value of $10,110.00. Following the completion of the sale, the director now directly owns 141,553 shares in the company, valued at approximately $477,033.61. This represents a 2.08 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Scott Robert Henry also recently made the following trade(s):

  • On Friday, December 20th, Scott Robert Henry sold 3,000 shares of NEXGEL stock. The shares were sold at an average price of $4.64, for a total value of $13,920.00.

NEXGEL Stock Performance

Shares of NXGL traded down $0.08 during mid-day trading on Wednesday, hitting $3.43. The company’s stock had a trading volume of 54,245 shares, compared to its average volume of 259,265. The stock’s 50-day moving average is $3.70 and its two-hundred day moving average is $3.00. The firm has a market capitalization of $23.29 million, a PE ratio of -5.91 and a beta of 0.61. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.93 and a current ratio of 1.51. NEXGEL, Inc. has a one year low of $1.84 and a one year high of $5.10.

Institutional Trading of NEXGEL

A hedge fund recently raised its stake in NEXGEL stock. Northeast Financial Group Inc. increased its position in NEXGEL, Inc. (NASDAQ:NXGLFree Report) by 168.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 31,848 shares of the company’s stock after purchasing an additional 20,000 shares during the quarter. Northeast Financial Group Inc. owned approximately 0.50% of NEXGEL worth $82,000 at the end of the most recent quarter. 2.21% of the stock is currently owned by hedge funds and other institutional investors.

About NEXGEL

(Get Free Report)

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.

Read More

Receive News & Ratings for NEXGEL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NEXGEL and related companies with MarketBeat.com's FREE daily email newsletter.